(Updated - June 22, 2026 6:35 AM EDT)

Leerink initiates coverage on Altimmune (NASDAQ: ALT) with a Outperform rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage